Financing channel feed – Endpoints News

Financing channel feed

Dutch biotech nabs €85M to position inflammatory antibody for a pharma buyer

5 months ago

Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune field

5 months ago

On heels of MariTide data, Danish obesity biotech discloses €80M Series A

5 months ago

After deal about-face and a spinout, Maze assembles $115M Series D

5 months ago

Revolution sells $600M in shares on back of RAS inhibitor portfolio updates

5 months ago

Agenus launches biologics manufacturing business to generate cash

5 months ago

Why Morgan Health is backing an autism care company

6 months ago

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

6 months ago

Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

6 months ago

Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January

6 months ago

Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy

6 months ago

Former NCI director teams up with serial entrepreneur for $70M VC fund targeting 'super-early' science

6 months ago

Exclusive: Synapticure raises $25M for its approach to virtual neurodegenerative disease care

6 months ago

Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise

6 months ago

Metsera raises $215M for studies of GLP-1 and amylin obesity drugs

6 months ago

TRexBio raises $84M to take in-house immune program into the clinic

6 months ago

Exclusive: GV-backed Medicaid startup Diverge Health raises $52M

6 months ago

Alentis nabs $181M to broaden Claudin's scope in ADCs

6 months ago

Maze's ALS spinout Trace Neuroscience raises $101M for ALS and neuro work

6 months ago

Pfizer to invest $1B in China over next five years — reports

6 months ago

Stephen Squinto's JPM life sciences team is raising a new fund for later-stage companies

6 months ago

Exclusive: Blood stem cell therapy maker Garuda gets new CEO, adds $47M

6 months ago

Evommune raises $115M for I&I pipeline and prepares for Phase 2 results

6 months ago

Blue Earth Therapeutics snags $76M for both alpha and beta radiotherapies

6 months ago

First page Previous page 4 5 678 9 10 Next page Last page